Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study

Background: Desensitization strategies improve access to transplantation in highly sensitized kidney transplant candidates. Tocilizumab could be a valuable addition to more traditional desensitization regimens. We investigated the effect of tocilizumab as an add-on therapy to our standard of care (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Jouve, Thomas, Daligault, Mélanie, Noble, Johan, Terrec, Florian, Imerzoukene, Farida, Dard, Céline, Bardy, Béatrice, Malvezzi, Paolo, Rostaing, Lionel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866000/
https://www.ncbi.nlm.nih.gov/pubmed/36675353
http://dx.doi.org/10.3390/jcm12020424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866000/
https://www.ncbi.nlm.nih.gov/pubmed/36675353
http://dx.doi.org/10.3390/jcm12020424

Ejemplares similares